Cold infections may be less frequent in people with the flu

People were less likely to catch either influenza or a common cold-causing rhinovirus if they were already infected with the other virus, a new study by scientists from the Medical Research Council-University of Glasgow Centre for Virus Research has found. Understanding how these distinct viruses inhibit each other could help public health planning to improve forecasting models that predict respiratory […]

Continue reading »

Psychotic experiences are quite common even among people who don’t have a mental health condition

Have you ever seen or heard something that turned out not to exist? Or have you ever thought something was happening that no one else noticed—perhaps thinking you were being followed, or that something was trying to communicate with you? If so, you may have had a psychotic experience. The good news is, you’re not alone. Psychosis, also called a […]

Continue reading »

Study: Active voice conveys a sense of immediacy and increases the chance people will believe you

The way we interpret a message changes depending on whether it’s framed in the active or the passive voice, University of Toronto researchers have found—even if the content is exactly the same. “What we found is that depending on which form you choose, it changes how your audience comes to understand that message,” says Sam Maglio, an associate professor in […]

Continue reading »

Fat mass index, not BMI, associated with cardiovascular events in people with diabetes

In people with diabetes, fat mass index, not body mass index (BMI), is associated with a higher risk of cardiovascular events, according to new research in CMAJ (Canadian Medical Association Journal). Heart disease is a major cause of death worldwide, and obesity is a major risk factor. Body mass index, a common measure of obesity, has been recently shown to […]

Continue reading »

NIH launches large TB prevention trial for people exposed to multidrug-resistant TB

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members […]

Continue reading »
1 2 3 5